Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001562230-25-000046
Filing Date
2025-02-14
Accepted
2025-02-14 13:32:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5698
  Complete submission text file 0001562230-25-000046.txt   7849
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Subject) CIK: 0000873303 (see all company filings)

EIN.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-54847 | Film No.: 25626237
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 333 SOUTH HOPE STREET 55TH FL LOS ANGELES CA 90071
Business Address 333 SOUTH HOPE STREET 55TH FL LOS ANGELES CA 90071 213-486-9200
Capital International Investors (Filed by) CIK: 0001562230 (see all company filings)

EIN.: 951411037 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G/A